246 related articles for article (PubMed ID: 28945888)
1. Estrogen Activation by Steroid Sulfatase Increases Colorectal Cancer Proliferation via GPER.
Gilligan LC; Rahman HP; Hewitt AM; Sitch AJ; Gondal A; Arvaniti A; Taylor AE; Read ML; Morton DG; Foster PA
J Clin Endocrinol Metab; 2017 Dec; 102(12):4435-4447. PubMed ID: 28945888
[TBL] [Abstract][Full Text] [Related]
2. Epigenetic down regulation of G protein-coupled estrogen receptor (GPER) functions as a tumor suppressor in colorectal cancer.
Liu Q; Chen Z; Jiang G; Zhou Y; Yang X; Huang H; Liu H; Du J; Wang H
Mol Cancer; 2017 May; 16(1):87. PubMed ID: 28476123
[TBL] [Abstract][Full Text] [Related]
3. G protein-coupled estrogen receptor (GPER) mediates NSCLC progression induced by 17β-estradiol (E2) and selective agonist G1.
Liu C; Liao Y; Fan S; Tang H; Jiang Z; Zhou B; Xiong J; Zhou S; Zou M; Wang J
Med Oncol; 2015 Apr; 32(4):104. PubMed ID: 25744245
[TBL] [Abstract][Full Text] [Related]
4. G protein-coupled estrogen receptor in colon function, immune regulation and carcinogenesis.
Jacenik D; Beswick EJ; Krajewska WM; Prossnitz ER
World J Gastroenterol; 2019 Aug; 25(30):4092-4104. PubMed ID: 31435166
[TBL] [Abstract][Full Text] [Related]
5. G protein-coupled estrogen receptor-1 agonist induces chemotherapeutic effect via ER stress signaling in gastric cancer.
Lee SJ; Kim TW; Park GL; Hwang YS; Cho HJ; Kim JT; Lee HG
BMB Rep; 2019 Nov; 52(11):647-652. PubMed ID: 31234952
[TBL] [Abstract][Full Text] [Related]
6. SIRT1 is involved in oncogenic signaling mediated by GPER in breast cancer.
Santolla MF; Avino S; Pellegrino M; De Francesco EM; De Marco P; Lappano R; Vivacqua A; Cirillo F; Rigiracciolo DC; Scarpelli A; Abonante S; Maggiolini M
Cell Death Dis; 2015 Jul; 6(7):e1834. PubMed ID: 26225773
[TBL] [Abstract][Full Text] [Related]
7. Estrone Sulfate Transport and Steroid Sulfatase Activity in Colorectal Cancer: Implications for Hormone Replacement Therapy.
Gilligan LC; Gondal A; Tang V; Hussain MT; Arvaniti A; Hewitt AM; Foster PA
Front Pharmacol; 2017; 8():103. PubMed ID: 28326039
[TBL] [Abstract][Full Text] [Related]
8. G protein-coupled estrogen receptor 1 (GPER 1) mediates estrogen-induced, proliferation of leiomyoma cells.
Jiang X; Ye X; Ma J; Li W; Wu R; Jun L
Gynecol Endocrinol; 2015; 31(11):894-8. PubMed ID: 26416628
[TBL] [Abstract][Full Text] [Related]
9. Hepatic steroid sulfatase critically determines estrogenic activities of conjugated equine estrogens in human cells
Feng Y; Xie Y; Xu M; Li L; Selcer KW; Oberly PJ; Poloyac SM; Wang H; Li C; Dong F; Yu C; Xie W
J Biol Chem; 2019 Aug; 294(32):12112-12121. PubMed ID: 31217279
[TBL] [Abstract][Full Text] [Related]
10. GPER mediates enhanced cell viability and motility via non-genomic signaling induced by 17β-estradiol in triple-negative breast cancer cells.
Yu T; Liu M; Luo H; Wu C; Tang X; Tang S; Hu P; Yan Y; Wang Z; Tu G
J Steroid Biochem Mol Biol; 2014 Sep; 143():392-403. PubMed ID: 24874276
[TBL] [Abstract][Full Text] [Related]
11. GPER mediates activation of HIF1α/VEGF signaling by estrogens.
De Francesco EM; Pellegrino M; Santolla MF; Lappano R; Ricchio E; Abonante S; Maggiolini M
Cancer Res; 2014 Aug; 74(15):4053-64. PubMed ID: 24894716
[TBL] [Abstract][Full Text] [Related]
12. Estrogen-mediated inactivation of FOXO3a by the G protein-coupled estrogen receptor GPER.
Zekas E; Prossnitz ER
BMC Cancer; 2015 Oct; 15():702. PubMed ID: 26470790
[TBL] [Abstract][Full Text] [Related]
13. Constitutive expression of the steroid sulfatase gene supports the growth of MCF-7 human breast cancer cells in vitro and in vivo.
James MR; Skaar TC; Lee RY; MacPherson A; Zwiebel JA; Ahluwalia BS; Ampy F; Clarke R
Endocrinology; 2001 Apr; 142(4):1497-505. PubMed ID: 11250930
[TBL] [Abstract][Full Text] [Related]
14. Oestrogen and colorectal cancer: mechanisms and controversies.
Foster PA
Int J Colorectal Dis; 2013 Jun; 28(6):737-49. PubMed ID: 23319136
[TBL] [Abstract][Full Text] [Related]
15. Steroid sulfatase and estrogen sulfotransferase in colon carcinoma: regulators of intratumoral estrogen concentrations and potent prognostic factors.
Sato R; Suzuki T; Katayose Y; Miura K; Shiiba K; Tateno H; Miki Y; Akahira J; Kamogawa Y; Nagasaki S; Yamamoto K; Ii T; Egawa S; Evans DB; Unno M; Sasano H
Cancer Res; 2009 Feb; 69(3):914-22. PubMed ID: 19141651
[TBL] [Abstract][Full Text] [Related]
16. Expression of 17beta-hydroxysteroid dehydrogenases and other estrogen-metabolizing enzymes in different cancer cell lines.
Smuc T; Rizner TL
Chem Biol Interact; 2009 Mar; 178(1-3):228-33. PubMed ID: 19022235
[TBL] [Abstract][Full Text] [Related]
17. Estradiol agonists inhibit human LoVo colorectal-cancer cell proliferation and migration through p53.
Hsu HH; Kuo WW; Ju DT; Yeh YL; Tu CC; Tsai YL; Shen CY; Chang SH; Chung LC; Huang CY
World J Gastroenterol; 2014 Nov; 20(44):16665-73. PubMed ID: 25469035
[TBL] [Abstract][Full Text] [Related]
18. Estrogen signaling through the G protein-coupled estrogen receptor regulates granulocyte activation in fish.
Cabas I; Rodenas MC; Abellán E; Meseguer J; Mulero V; García-Ayala A
J Immunol; 2013 Nov; 191(9):4628-39. PubMed ID: 24062489
[TBL] [Abstract][Full Text] [Related]
19. Steroid sulfatase mediated growth Sof human MG-63 pre-osteoblastic cells.
Dias NJ; Selcer KW
Steroids; 2014 Oct; 88():77-82. PubMed ID: 25042472
[TBL] [Abstract][Full Text] [Related]
20. Steroid sulfatase and estrogen sulfotransferase in human endometrial carcinoma.
Utsunomiya H; Ito K; Suzuki T; Kitamura T; Kaneko C; Nakata T; Niikura H; Okamura K; Yaegashi N; Sasano H
Clin Cancer Res; 2004 Sep; 10(17):5850-6. PubMed ID: 15355916
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
